Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology 31. October 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 99296  Previews Next
   
   Articles 1 - 20 / 1985909  
   
Profiling the MMP family genes as prognostic biomarkers in oral squamous cell carcinoma: from computational discovery to clinical validation in a South Indian cohort.
Front Bioinform
Sakthi Subhashini P, Bharanidharan T, Suresh Kumar D, Asha Devi S.
PMID: 42964316 [PubMed - as supplied by publisher]


Addressing unmet clinical needs in treatment-resistant breast cancer: expanding the diagnostic-prognostic landscape through next-generation inflammatory signatures.
Oncol Rev
Obeagu EI.
PMID: 42964275 [PubMed - as supplied by publisher]


The synergistic potential of combining PD-1/PD-L1 inhibitors with conventional therapies in esophageal squamous cell carcinoma.
Front Pharmacol
Li R, Heng Z, Cheng X.
PMID: 42964272 [PubMed - as supplied by publisher]


A predefined sulphur-handling transcriptional programme is associated with colorectal cancer molecular subtypes.
Front Oncol
Shafi S, Hamid A, Yang J, Cheng X, Sun M.
PMID: 42964170 [PubMed - as supplied by publisher]


Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study.
Front Oncol
Gencer H, Ucar G, Alg, Sendur MAN, Bostanci EB.
PMID: 42964134 [PubMed - as supplied by publisher]


Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction - a feasibility, safety, and pharmacokinetic study.
Front Oncol
Gwee YX, Wong ALA, Goh BC, Soo RA, Yong WP, Tan DSP, Chee CE, Lim SE, Ang Y, Huang Y, Chong WQ, Lim J, Chan G, Ngoi N, Ow S, Wong R, Sooi K, Choo J, Lee SC.
PMID: 42964102 [PubMed]


Global thyroid cancer incidence in relation to dietary and socioeconomic factors: an ecological machine learning study.
Front Oncol
Li Y, Liu D, Qin R, Li X, Li M.
PMID: 42964100 [PubMed]


A systematic review of the effects of diet on the gut microbiota in individuals at elevated risk for colorectal cancer.
Front Nutr
Pandey S, Skidmore J, Dhillon J.
PMID: 42964076 [PubMed]


Postoperative ctDNA could potentially spare patients from unnecessary adjuvant therapy in HPV-negative head and neck squamous cell carcinoma: a meta-analysis.
Front Oncol
Asad MR, Pusarico AF, Reji N, AlRamadneh TN, Khan AU.
PMID: 42964065 [PubMed]


Comparative efficacy of fruquintinib, regorafenib or TAS-102 in patients with KRAS-mutant metastatic colorectal cancer: a systematic review and network meta-analysis.
Front Oncol
Zhou Y, Zhao S, Zheng X, Wang Y, Wang M, Chen S, Wu Z, Zang D, Si W.
PMID: 42964049 [PubMed]


Serial urinary NGAL and CK20 for dynamic cardiovascular risk stratification in non-muscle-invasive bladder cancer: a retrospective clinical cohort study.
Front Cardiovasc Med
Ma W, Liu Y, Tang L, Ouyang S, Ma Y, Zhang Z, Li Q, Li Z, Li L, Zhao Y.
PMID: 42964030 [PubMed]


Lenvatinib starting doses below 20 mg versus 20 mg with pembrolizumab in advanced or recurrent endometrial cancer: a systematic review and meta-analysis of comparative observational evidence.
Front Oncol
Wu Y, Wei J, Chang C, Li M, Xu R, Dong S, Jiang M.
PMID: 42964024 [PubMed]


Clinical Significance of Indeterminate Antibody to Hepatitis C in Cancer Patients.
J Viral Hepat
Pascucci JA, Mustafayev K, Jiang Y, Raad I, Guevara EY, Torres HA.
PMID: 42963989 [PubMed - indexed for MEDLINE]


Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
Med J Aust
Symonds EL, Bonevski B, Edwards R, Harrison NJ, Ishaque S, Rankin NM, Saya S, Smith RJ, Ee C.
PMID: 42963966 [PubMed - indexed for MEDLINE]


Ascites Presenting as a Peritonitis-Like Manifestation and Liver Injury due to Trabectedin Monotherapy in a Patient With Myxoid Liposarcoma.
Cancer Rep (Hoboken)
Kawahara T, Yamane H, Mimura A, Kirishi H, Sunada Y, Kosaka Y, Ichiyama N, Nagasaki Y, Ochi N, Nakanishi H, Fujiwara H, Takigawa N.
PMID: 42963961 [PubMed - indexed for MEDLINE]


Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol-Associated Liver Disease.
Liver Int
Pizarro G, Alcayaga B, Rama K, González-Montero J, Arrese M, Arab JP, Díaz LA.
PMID: 42963959 [PubMed - indexed for MEDLINE]


Cancer in Seychelles: A Population-Based Study on Incidence, Trends and Stage at Diagnosis (2005-2024).
Int J Cancer
Finesse A, Mondon J, Shroff E, Gedeon J, Louange M, Parkin DM.
PMID: 42963954 [PubMed - as supplied by publisher]


A multicenter, prospective, phase 2 trial on proton re-irradiation for patients with previously treated head and neck cancer.
Cancer
Dee EC, Barker CA, Kalman NS, Wu Y, White C, Zhang Z, Lin H, Gelblum DY, Yu Y, Kang JJ, Tsai CJ, Zakeri K, Chen L, McBride SM, Shamseddine A, Michel LS, Dunn LA, Ho AL, Cohen MA, Ganly I, Cracchiolo JR, Wong RJ, Romesser PB, Riaz N, Sherman EJ, Lee NY.
PMID: 42963935 [PubMed - indexed for MEDLINE]


The evolving role of perioperative systemic therapy in bladder cancer.
Cancer
Atiq SO, Anker JF, Miller EJ, Karol AB, Mehrazin R, Sfakianos JP, Galsky MD.
PMID: 42963929 [PubMed - indexed for MEDLINE]


Macular OCTA Biomarkers of Ocular Involvement in Patients With Primary Central Nervous System Lymphoma.
Hematol Oncol
Zhu T, Li Q, Zhang Y, Peng G, Wang Z, Zhang Y.
PMID: 42963924 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 1985909    Page 1 of 99296  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1